News Roundup: March 28 to April 1
Your weekly roundup of the latest news from Drug Topics®.
Manage Your Stress for Your Best Health
A personal medical diagnosis led one pharmacist on a journey of health and healing.
Challenges for States as Public Health Emergency Ends
There are no easy solutions for people who gained insurance coverage through Medicaid.
Optimizing Off-Label Use of Bioloogics, New Medications
Experts explored out-of-the-box solutions for treating challenging skin and hair disorders at the American Academy of Dermatology (AAD)’s 2022 Annual Meeting.
How to Treat Acne in Transgender Patients on Testosterone
Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.
ADHD Update: Newest Medications, Reviewed
At the 43rd National Conference on Pediatric Health Care for nurse practitioners in Dallas, Texas, a look at the newest medications for children with attention-deficit/hyperactivity disorder.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
